Abstract:It is well established that many receptors couple to G-proteins in order to subserve their pharmacological or physiological effects. In those systems it is possible that a ternary complex mechanism operates in which initiation of an effect depends on the concentration of agonist-receptor-G-protein complex formed. Such systems may be considered to obey a receptor-transducer model (Black & Leff, 1983, Proc. R. Soc. B220, 141). A theoretical analysis of this model is presented which seeks to determine how the operation of the ternary complex mechanism affects the quantification of agonists by conventional pharmacological methods. Previous analyses have concluded that pharmacological models may or may not accommodate the ternary complex mechanism depending upon the relationship between the relative concentrations of receptor and transducer units, [R0], and [T0] respectively. The present study extends these in two ways. It considers the impact of the ternary complex mechanism on agonist quantification under a more complete range of conditions relating [R0] and [T0], and it does so with regard to the analysis of partial agonists (by the comparative method) as well as of full agonists (by the method of receptor inactivation). The following predictions are made: (i) reliable estimates of affinity and efficacy can be made using the comparative method under the conditions [R0] much greater than [T0] and [R0] much less than [T0] whereas the inactivation method only works under the former condition; (ii) errors occur in the estimation of affinity and efficacy by both methods when [R0] = [T0] although better estimates are produced by the comparative method; (iii) when errors occur in the absolute estimation of affinity and efficacy, the orders of affinity and efficacy determined by the comparative method will generally be correct but this is not the case for the inactivation method; (iv) in general, the comparative method for agonist quantification appears to produce more reliable information for the purposes of receptor classification and medicinal chemistry than does the receptor inactivation method.

The Evolution of Drug-Receptor Models: The Cubic Ternary Complex Model for G Protein-Coupled Receptors

The Cubic Ternary Complex ReceptorOccupancy Model I. Model Description

Theoretical Aspects of GPCR-Ligand Complex Pharmacology

Algebraic Study of Receptor-Ligand Systems: A Dose-Response Analysis

Mechanism of psychoactive drug action in the brain: simulation modeling of GABAA receptor interactions at non-equilibrium conditions

Revising Berg-Purcell for finite receptor kinetics

Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates?

Application of an Allosteric Ternary Complex Model to the Technique of Pharmacological Resultant Analysis

A 19F-qNMR-Guided Mathematical Model for G Protein-Coupled Receptor Signaling

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

A Thermodynamic Model for Receptor Clustering

Dopaminergic Pharmacology Revealed by Structures of Human Dopamine D3 Receptor-G I Complexes

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Computational Modeling for the Activation Cycle of G-proteins by G-protein-coupled Receptors

The Novel Application of Geometric Morphometrics with Principal Component Analysis to Existing G Protein-Coupled Receptor (GPCR) Structures

Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.

Quantification of Signal Amplification for Receptors: The K /EC Ratio of Full Agonists as a Gain Parameter

A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

Recent Trends and Applications of Molecular Modeling in GPCR–Ligand Recognition and Structure-Based Drug Design

Receptor Surface Models. 2. Application to Quantitative Structure-Activity Relationships Studies

A simple model for a regulatory enzyme